GlaxoSmithKline Pharmaceuticals Ltd. డివిడెండ్ చరిత్ర & చెల్లింపు తేదీ

సంవత్సరం/నెల	ఎఫెక్టివ్ తేదీ	డివిడెండ్ తేదీ	డివిడెండ్(%) (%)	రిమార్క్స్
May 13, 2026	May 29, 2026	Final	570	Rs.57.0000 per share(570%)Final Dividend
May 13, 2025	May 30, 2025	Final	420	Rs.42.0000 per share(420%)Final Dividend
Oct 24, 2024	Nov 07, 2024	Interim	120	Rs.12.0000 per share(120%)Interim Dividend
May 17, 2024	May 31, 2024	Final	320	Rs.32.0000 per share(320%)Final Dividend
May 17, 2023	Jun 30, 2023	Final	320	Rs.32.0000 per share(320%)Final Dividend
May 17, 2022	Jul 07, 2022	Special	600	Rs.60.0000 per share(600%)Special Dividend
May 16, 2022	Jul 07, 2022	Final	300	Rs.30.0000 per share(300%)Dividend
May 18, 2021	Jul 19, 2021	Final	300	Rs.30.0000 per share(300%)Dividend
May 19, 2020	Jul 17, 2020	Special	200	Rs.20.0000 per share(200%)Special Dividend
May 18, 2020	Jul 17, 2020	Final	200	Rs.20.0000 per share(200%)Final Dividend
May 20, 2019	Jul 11, 2019	Final	200	Rs.20.0000 per share(200%)Dividend
May 24, 2018	Jul 13, 2018	Final	350	Rs.35.0000 per share(350%)Dividend
May 19, 2017	Jul 14, 2017	Final	300	Rs.30.0000 per share(300%) Dividend.
May 25, 2016	Jul 15, 2016	Final	500	Rs.50.0000 per share(500%)Dividend
May 18, 2015	Jul 23, 2015	Final	625	Rs.62.5000 per share(625%)Dividend
Feb 18, 2014	Apr 03, 2014	Final	500	Rs.50.0000 per share(500%)Dividend
Feb 19, 2013	Apr 04, 2013	Final	500	Rs.50.0000 per share(500%)Dividend
Feb 16, 2012	Mar 29, 2012	Final	450
Feb 14, 2011	Mar 14, 2011	Final	400
Feb 15, 2010	Mar 10, 2010	Final	300
Feb 18, 2009	Mar 18, 2009	Final	400	(Rs. 22/-per eq.share + Sp.Add.Div.of Rs. 18/-per equity share)
Feb 22, 2008	Apr 02, 2008	Final	360	(Div. of Rs. 18/- per eq.sh. + Special Div.of Rs. 18/- per eq. sh. = Rs. 36/- per eq. sh.)
Mar 05, 2002	Mar 27, 2002	Final	55
Mar 23, 2001	May 02, 2001	Final	50
Apr 16, 1997		Final	25

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article